Smith Thornton Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
4,330
+149
+4% +$34.7K 0.49% 53
2026
Q1
$1.02M Sell
4,181
-21
-0.5% -$4.89K 0.51% 52
2025
Q4
$870K Buy
4,202
+36
+0.9% +$7.12K 0.44% 57
2025
Q3
$773K Buy
4,166
+118
+3% +$20.2K 0.41% 61
2025
Q2
$618K Buy
4,048
+104
+3% +$16K 0.36% 69
2025
Q1
$654K Buy
3,944
+35
+0.9% +$5.48K 0.41% 63
2024
Q4
$565K Buy
3,909
+96
+3% +$14.9K 0.36% 71
2024
Q3
$618K Buy
3,813
+241
+7% +$38.4K 0.41% 70
2024
Q2
$522K Buy
+3,572
New +$531K 0.38% 71

Other funds holding JNJ

Smith Thornton Advisors's JNJ Position: Q2 2026 in Review

Smith Thornton Advisors increased its Johnson & Johnson (JNJ) stake by 3.6% in Q2 2026, buying an estimated $34.7K and bringing the position to 4,330 shares worth $1.12M. The position accounts for 0.49% of the portfolio, ranked #53.

Smith Thornton Advisors first reported a position in JNJ in Q2 2024 and has held it in 9 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Smith Thornton Advisors held 4,330 shares of Johnson & Johnson worth $1.12M as of Q2 2026.
  • Smith Thornton Advisors bought 149 Johnson & Johnson shares in Q2 2026, an estimated $34.7K.
  • Johnson & Johnson made up 0.49% of Smith Thornton Advisors's portfolio in Q2 2026, its #53 holding.
  • Smith Thornton Advisors first reported a position in Johnson & Johnson in Q2 2024 and has held it in 9 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Smith Thornton Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.